Polymorphism located in promoter of CTLA-4 gene is not associated with type 1 diabetes in contrast to A→G transition within exon 1

Biomedical Letters

Volumn 58, Issue 230, 1998, Pages 163-168

  Witas, H W ^a   Mlynarski W ^a   Sychowski, R ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

CTLA 4 gene; IDDM; Promoter polymorphism; Type 1 diabetes

Indexed keywords

EID: 0039392175     PISSN: 0961088X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. BOISE L. H., Minn A. J., Noel P. J., June C. H., Accavitti M. A., Lindsten T. and Thompson C.B. 1995. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3 87-9.
2. DEICHMANN K., Heinzmann A., Bruger olte E., Foster J. and Kuehr J. 1996. An Mse I RFLP in the human CTLA-4 promotor. Biochem. biophys. Res. Commun. 225 817-8.
3. GRIBBEN J. G., Freeman G. J., Boussiotis V. A., Rennert P., Jellis C. L., Greenfield E., Barber M., Restivo V. A. Jr, Ke X. and Gray G. S. 1995. CTLA-4 mediates antigen specific apoptosis of human T cells. Proc. natn. Acad. Sci. U.S.A. 92 811-5.
4. KARIV I., Truneh A. and Sweet R. W. 1996. Analysis of the site of interaction of CD28 with its counter-receptors CD80 and CD86 and correlation with function. J. Immunol. 157 29-38.
5. MORAHAN G., Huang D., Tait B. D., Colman P. G. and Harrison L. C. 1996. Markers on distal chromosome 2q linked to insulin-dependent diabetes mellitus. Science 272 1811-3.
6. NISTICO L., Buzzetti R., Pritchard L. E., Van der Auwera B., Giovannini C., Bosi E., Larrad M. T., Rios M. S., Chow C. C., Cockram C. S., Jacobs K., Mijovic C., Bain S. C., Barnett A. H., Vandewalle C. L., Schult F., Gorus F. K., Tosi R., Pozzilli P. and Todd J. A. 1996. The CTLA-4 gene region of chromosome 2q33 is linked, and associated with type 1 diabetes. Hum. Molec. Genet. 5 1075-80.
7. OWERBACH D., Naya F. J., Tsai M. J., Allander S. V., Powell D. R. and Gabbay K. H. 1997. Analysis of candidate genes for susceptibility to type I diabetes: a case-control and family-association study of genes on chromosome 2q31-35. Diabetes 46 1069-74.
8. VAN DER AUWERA B. J., Vandewalle C. L., Schuit F. C., Winnock F., De Leeuw I. H., Van Imschoot S., Lamberigts G. and Gorus F. K. 1997. CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. Clin. exp. Immunol. 110 98-103.
9. WARD S. G. 1996. CD28: a signalling perspective. Biochem. J. 318 361-77.
10. WOOLF B. 1955. On estimating the relation between blood group and disease. Ann. hum. Genet. 19 251-3.